Sleep-Disordered Breathing (SDB)
Definition
Sleep-disordered breathing (SDB) is an umbrella term for breathing abnormalities that occur specifically during sleep, encompassing obstructive sleep apnea (OSA), central sleep apnea (CSA), and CSA–Cheyne-Stokes breathing (CSB). Affecting approximately 1 billion adults worldwide, SDB is strongly associated with cardiac arrhythmogenesis — including atrial fibrillation, ventricular tachyarrhythmias, sudden cardiac death, and bradyarrhythmias — through a multilayered pathophysiological framework operating across immediate, subacute, and chronic timeframes.
Key Concepts
SDB Subtypes
(sources/sdb-arrhythmia-aha-2022, rating: very high)
Obstructive Sleep Apnea (OSA)
- Repetitive occlusion/narrowing of the upper airway → apneas (complete cessation ≥10 sec) and hypopneas (partial flow reduction with ≥3–4% O₂ desaturation or microarousal).
- Defined by AHI ≥5/h with typical symptoms or AHI ≥15/h regardless of symptoms.
- Most common and clinically significant SDB subtype; affects an estimated 1 billion adults.
- Daytime sleepiness poorly correlates with SDB severity in cardiac disease — symptom-based screening unreliable in AF patients.
Central Sleep Apnea (CSA)
- Transient cessation of or decrease in ventilatory effort generated by the pontomedullary respiratory pacemaker.
- Results from CO₂ falling below the apneic threshold → breathing cessation.
- Defined as >50% of apneas/hypopneas classified as central.
- No reliable screening questionnaires available for CSA.
CSA–Cheyne-Stokes Breathing (CSB)
- Form of CSA common in heart failure; heightened ventilatory chemosensitivity → alternating crescendo-decrescendo apneic and hyperpneic ventilatory periods.
- Bidirectional relationship: delayed circulation time + poor LV function → CSA/CSB; conversely, SDB hypoxia + sympathetic activation → exacerbates cardiac dysfunction.
- Ventricular ectopy in CSB increases during the hyperpneic phase (chemostimulation peak), not the apneic phase — distinct from OSA arrhythmogenesis.
Mixed and Variable SDB
- OSA and CSA can alternate in a single night; recumbency causes rostral fluid redistribution → upper airway edema → obstructive events; pulmonary congestion → hyperventilation → CO₂ below apneic threshold → central events.
Diagnostic Metrics
Apnea-Hypopnea Index (AHI) (sources/sdb-arrhythmia-aha-2022, rating: very high; sources/osa-af-jama-2018, rating: high)
- Standard severity metric (events/hour of sleep).
- Significant limitations: does not capture absolute degree or duration of O₂ desaturation; cannot distinguish short/mild from long/severe events; poorly predicts cardiovascular arrhythmic risk in some cohorts.
Oxygen Desaturation Index (ODI) (sources/sdb-arrhythmia-aha-2022, rating: very high)
- Frequency of oxygen desaturations derived from overnight oximetry; AUC 0.95 for ruling out moderate-to-severe OSA (AHI ≥15) — accessible and validated in AF populations.
- May be a superior predictor of AF risk and SCD than AHI.
Nocturnal Hypoxic Burden
- In 8,256 patients, nocturnal hypoxia (not AHI) independently predicted incident AF (HR 2.47 [95% CI 1.64–3.71]) after controlling for confounders. (sources/sdb-arrhythmia-aha-2022)
- SCD independently predicted by mean nocturnal O₂ sat <93% (HR 2.93) and nadir <78% (HR 2.60) — superior to AHI as SCD predictor. (sources/sdb-arrhythmia-aha-2022)
SDB Endotypes
(sources/sdb-arrhythmia-aha-2022, rating: very high)
- SDB pathophysiological basis is heterogeneous; individuals differ in:
- Anatomic risk factors (craniofacial morphology, patterns of adiposity; varies by ancestry)
- Low cortical arousal threshold — CPAP less well tolerated; medications raising arousal threshold may be more effective; associated with shorter apnea/hypopnea duration in MESA Black women
- Poor upper airway muscle responsiveness
- Increased upper airway collapsibility
- Elevated loop gain (ventilatory instability biomarker; common in heart failure) — may respond better to supplemental oxygen than CPAP
- Higher heart rate response to discrete respiratory events predicts incident cardiovascular disease and HF; being investigated as AF predictor.
- Personalized therapy based on endotyping — derived from routine polysomnography — is an emerging approach.
Diagnosis
(sources/sdb-arrhythmia-aha-2022, rating: very high)
- In-laboratory polysomnography (PSG): Gold standard; mandatory in AF + HF (CSA/CSB suspected), pulmonary/neurological comorbidities, or treatment-emergent CSA.
- Home sleep apnea testing (HSAT): Validated in AF population against PSG; sufficient for diagnosing OSA in most AF patients without major comorbidities.
- OSA Screening questionnaires in AF:
- STOP-BANG: AUC 0.73 for paroxysmal AF
- NABS (Neck circumference, Age, BMI, Snoring): AUC 0.82 for paroxysmal AF — validated and superior to STOP-BANG
- Epworth Sleepiness Scale: only 32% sensitivity in AF patients — not adequate alone (sources/osa-af-jama-2018)
- Absence of daytime sleepiness cannot reliably exclude OSA in cardiac patients
- High night-to-night AHI variability → repeat testing warranted if clinical suspicion persists despite initial negative test.
- Wearable devices using AI for simultaneous sleep + cardiac physiological monitoring — emerging diagnostic and management role.
SDB and Cardiac Arrhythmia — Temporal Pathophysiology
(sources/sdb-arrhythmia-aha-2022, rating: very high)
Immediate (during each apnea/hypopnea):
- Autonomic NS fluctuations (parasympathetic activation → sympathetic surge at apnea termination)
- Repetitive intermittent hypoxia and CO₂ alterations
- Intrathoracic pressure alterations (OSA: up to −60 mmHg)
- AERP shortening, dynamic QT prolongation, EADs/DADs, premature atrial contractions
Subacute (days to weeks):
- Direct cardiac mechanical influences: atrial distension, ↑LV pressure, ↑transmural gradient
- Electrophysiological alterations: reduced AERP, electromechanical window shortening
- Systemic inflammation and oxidative stress
Chronic:
- Structural and electrophysiological cardiac remodeling
- CaMKII-dependent phosphorylation of sodium channels
- Connexin dysregulation → atrial conduction abnormalities
- Atrial and ventricular fibrosis
- Epicardial fat secretome → facilitates atrial substrate progression
- Metabolic dysregulation
Circadian Biology of SDB
(sources/sdb-arrhythmia-aha-2022, rating: very high)
- Central circadian clock directly affects cardiac electrophysiology through the autonomic NS and local cardiac clock influences ion channel expression.
- Clock gene regulation of atrial K⁺ channels (Kv1.5, Kv4.2) modulates atrial arrhythmic substrate.
- KLF15 (Krüppel-like factor 15): Deficiency or gain-of-function → loss of rhythmic QT variation → abnormal repolarization → ↑VTA and SCD risk.
- REM sleep timing (peak autonomic instability and most obstructive apneas) is regulated by central circadian mechanisms.
- Nocturnal SCD predilection in OSA: relative risk 2.57 (midnight–6AM) vs. non-OSA patients whose SCD is distributed uniformly throughout the day.
SDB and AF — Key Epidemiological Associations
(sources/sdb-arrhythmia-aha-2022, rating: very high; sources/osa-af-jama-2018, rating: high)
- OSA prevalence in AF: 21–74%; nearly 5-fold higher odds of AF in moderate-to-severe SDB.
- CSA associated with 5.3–6.5 year excess AF risk; OSA also associated with AF independently.
- VARIOSA-AF: Nights with highest SDB severity had 2× the likelihood of ≥1 hour of AF the following day; AF episodes did not predict respiratory events — directionality confirmed.
- SDB magnitude of association with AF (HR 2.18) exceeds obesity-AF association (HR 1.49).
SDB and Ventricular Arrhythmia/SCD
(sources/sdb-arrhythmia-aha-2022, rating: very high)
- 2-fold higher odds of NSVT; 50% higher odds of complex ventricular ectopy in SDB.
- SCD independently predicted by nocturnal hypoxia (AHI >20: HR 1.60; mean O₂ sat <93%: HR 2.93; nadir <78%: HR 2.60).
- Nocturnal SCD relative risk 2.57 in OSA (midnight–6AM).
SDB and Bradyarrhythmias
(sources/sdb-arrhythmia-aha-2022, rating: very high)
- Bradyarrhythmias (sinus bradycardia, sinus pauses, AV block) are the most common cardiac arrhythmias during sleep in SDB.
- Prevalence of nocturnal sinus bradycardia 7.2–40%; sinus pauses 3.3–33%; 2nd/3rd degree AV block 1.3–13.3%.
- AHI-severity threshold for heart block: none at AHI <60/h; 17.5% at AHI ≥60/h.
- CPAP eliminates AV block in most treated patients.
- ACC/AHA/HRS guidance: Screen and treat SDB before pacemaker implantation in sleep-related bradyarrhythmias; do not pace for sleep-related sinus bradycardia/pauses without other indications.
Contradictions / Open Questions
- CPAP for AF — biological vs. clinical evidence gap: Three RCTs (SAVE, Caples, Traaen) all failed to confirm CPAP benefit on AF outcomes despite compelling mechanistic and observational data. Trials were limited by underpowering, inadequate monitoring, lower-than-anticipated AF burden, and short follow-up. (sources/sdb-arrhythmia-aha-2022)
- AHI vs. nocturnal hypoxic burden: Which SDB severity metric best predicts arrhythmia risk is unresolved; AHI is standard but may be inferior to ODI or nocturnal O₂ saturation-based metrics. (sources/sdb-arrhythmia-aha-2022, sources/osa-af-jama-2018)
- CSA causality in AF: Bidirectional relationship — AF-induced circulatory delay → CSA; SDB → cardiac dysfunction → CSA. Separating cause from effect is methodologically difficult. (sources/sdb-arrhythmia-aha-2022)
- SERVE-HF paradox: ASV reduces CSB in HFrEF but increases cardiovascular mortality; the mechanism is unclear; how to address CSB-related VTA without ASV is unresolved. (sources/sdb-arrhythmia-aha-2022)
- Optimal treatment timing: Whether early SDB treatment prevents structural remodeling vs. whether benefit differs based on AF stage (paroxysmal vs. persistent) is unknown. (sources/sdb-arrhythmia-aha-2022)
- SDB endotype–treatment matching: Which endotype benefits most from CPAP vs. supplemental oxygen vs. neurostimulation vs. pharmacotherapy is largely unresolved. (sources/sdb-arrhythmia-aha-2022)
Connections
- Related to entities/Obstructive-Sleep-Apnea
- Related to concepts/OSA-Arrhythmogenic-Substrate
- Related to entities/Atrial-Fibrillation
- Related to entities/Heart-Failure
- Related to concepts/Sudden-Cardiac-Death
- Related to concepts/Catheter-Ablation-AF
- Related to concepts/AF-CARE